Gunnar Folprecht
Gunnar Folprecht
University hospital Carl Gustav Carus, University Cancer Center, Dresden, Germany
Verified email at mailbox.org - Homepage
Title
Cited by
Cited by
Year
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer
E Van Cutsem, CH Köhne, E Hitre, J Zaluski, CR Chang Chien, ...
New England Journal of Medicine 360 (14), 1408-1417, 2009
40672009
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS …
E Van Cutsem, CH Kohne, I Láng, G Folprecht, MP Nowacki, S Cascinu, ...
J Clin Oncol 29 (15), 2011-2019, 2011
18922011
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
G Folprecht, T Gruenberger, WO Bechstein, HR Raab, F Lordick, ...
The lancet oncology 11 (1), 38-47, 2010
10262010
Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates
G Folprecht, A Grothey, S Alberts, HR Raab, CH Köhne
Annals of Oncology 16 (8), 1311-1319, 2005
7352005
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of …
C Rödel, T Liersch, H Becker, R Fietkau, W Hohenberger, T Hothorn, ...
The lancet oncology 13 (7), 679-687, 2012
6172012
KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience
E Van Cutsem, I Lang, G D'haens, V Moiseyenko, J Zaluski, G Folprecht, ...
Journal of Clinical Oncology 26 (15_suppl), 2-2, 2008
5242008
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final …
C Rödel, U Graeven, R Fietkau, W Hohenberger, T Hothorn, D Arnold, ...
The Lancet Oncology 16 (8), 979-989, 2015
4642015
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced …
SE Al-Batran, N Homann, C Pauligk, TO Goetze, J Meiler, S Kasper, ...
The Lancet 393 (10184), 1948-1957, 2019
4452019
Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy
N Halama, S Michel, M Kloor, I Zoernig, A Benner, A Spille, ...
Cancer research 71 (17), 5670-5677, 2011
3422011
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic …
G Folprecht, MP Lutz, P Schöffski, T Seufferlein, A Nolting, P Pollert, ...
Annals of Oncology 17 (3), 450-456, 2006
2902006
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials
G Folprecht, D Cunningham, P Ross, B Glimelius, F Di Costanzo, J Wils, ...
Annals of Oncology 15 (9), 1330-1338, 2004
2602004
Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized …
G Folprecht, MT Seymour, L Saltz, JY Douillard, H Hecker, RJ Stephens, ...
Journal of Clinical Oncology 26 (9), 1443-1451, 2008
2412008
Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial
T Ruers, F Van Coevorden, CJA Punt, JPEN Pierie, I Borel-Rinkes, ...
JNCI: Journal of the National Cancer Institute 109 (9), djx015, 2017
2392017
Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for …
SE Al-Batran, N Homann, H Schmalenberg, HG Kopp, GM Haag, ...
Journal of Clinical Oncology 35 (15_suppl), 4004-4004, 2017
2392017
Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
F Lordick, B Luber, S Lorenzen, S Hegewisch-Becker, G Folprecht, E Wöll, ...
British journal of cancer 102 (3), 500-505, 2010
2242010
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
J Taieb, J Tabernero, E Mini, F Subtil, G Folprecht, JL Van Laethem, ...
The lancet oncology 15 (8), 862-873, 2014
2172014
Chemotherapy in elderly patients with colorectal cancer
CH Köhne, G Folprecht, RM Goldberg, E Mitry, P Rougier
The oncologist 13 (4), 390-402, 2008
209*2008
Chemotherapy in elderly patients with colorectal cancer
CH Köhne, G Folprecht, RM Goldberg, E Mitry, P Rougier
The oncologist 13 (4), 390-402, 2008
209*2008
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)
G Folprecht, T Gruenberger, W Bechstein, HR Raab, J Weitz, F Lordick, ...
Annals of oncology 25 (5), 1018-1025, 2014
1972014
Prognostic value of BRAF and KRAS mutations in MSI and MSS stage III colon cancer
J Taieb, K Le Malicot, Q Shi, F Penault-Llorca, O Bouché, J Tabernero, ...
JNCI: Journal of the National Cancer Institute 109 (5), 2017
1342017
The system can't perform the operation now. Try again later.
Articles 1–20